Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score

INTRODUCTION: We aimed to evaluate the outcome of treatment with docetaxel plus androgen deprivation therapy (ADT) in newly diagnosed patients with metastatic high tumor burden hormone-sensitive prostate cancer (mHSPC) and correlated the outcome with hemoglobin, albumin, lymphocyte and platelets (HA...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Heba F., Elsayed, Dalia Hamouda, Salem, Reham, Mandour, Doaa, Bayomy, Mohammed, Rashed, Hayam, Kamel, Mostafa, Elderey, Mohamed, Elfarargy, Ola M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641632/
https://www.ncbi.nlm.nih.gov/pubmed/36381673
http://dx.doi.org/10.5114/wo.2022.120592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641632/
https://www.ncbi.nlm.nih.gov/pubmed/36381673
http://dx.doi.org/10.5114/wo.2022.120592

Ejemplares similares